These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 32669380)

  • 1. Performance of Four Fosfomycin Susceptibility Testing Methods against an International Collection of Clinical Pseudomonas aeruginosa Isolates.
    Smith EC; Brigman HV; Anderson JC; Emery CL; Bias TE; Bergen PJ; Landersdorfer CB; Hirsch EB
    J Clin Microbiol; 2020 Sep; 58(10):. PubMed ID: 32669380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of disk diffusion and broth microdilution for fosfomycin susceptibility testing of multidrug-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa.
    Mojica MF; De La Cadena E; Hernández-Gómez C; Correa A; Appel TM; Pallares CJ; Villegas MV
    J Glob Antimicrob Resist; 2020 Jun; 21():391-395. PubMed ID: 32004722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of Clinical Isolates of Escherichia coli to Fosfomycin as Measured by Four
    Karlowsky JA; Lagacé-Wiens PRS; Laing NM; Baxter MR; Adam HJ; Zhanel GG
    J Clin Microbiol; 2020 Sep; 58(10):. PubMed ID: 32817224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of fosfomycin against a collection of clinical Pseudomonas aeruginosa isolates from 16 Spanish hospitals: establishing the validity of standard broth microdilution as susceptibility testing method.
    Díez-Aguilar M; Morosini MI; del Campo R; García-Castillo M; Zamora J; Cantón R
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5701-3. PubMed ID: 23939889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fosfomycin Susceptibility Testing Using Commercial Agar Dilution Test.
    Croughs PD; Konijnendijk-de Regt M; Yusuf E
    Microbiol Spectr; 2022 Apr; 10(2):e0250421. PubMed ID: 35352940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of fosfomycin against bacterial pathogens isolated from urine specimens in Canada from 2007 to 2020: CANWARD surveillance study.
    Karlowsky JA; Baxter MR; Walkty AJ; Lagacé-Wiens PRS; Bay D; Adam HJ; Zhanel GG
    J Antimicrob Chemother; 2022 Oct; 77(11):3035-3038. PubMed ID: 35971759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Fosfomycin Etest To Determine
    Karlowsky JA; Baxter MR; Golden AR; Adam HJ; Walkty A; Lagacé-Wiens PRS; Zhanel GG
    J Clin Microbiol; 2021 Nov; 59(12):e0163521. PubMed ID: 34495708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of In vitro Efficacy of Meropenem/Colistin and Meropenem/Fosfomycin Combinations on Multidrug Resistant Gram-Negative Bacilli].
    Adaleti R; Nakipoğlu Y; Arıcı N; Kansak N; Çalık Ş; Şenbayrak S; Balık R; Aksaray S
    Mikrobiyol Bul; 2023 Jul; 57(3):365-377. PubMed ID: 37462301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skipped wells and scientific error during fosfomycin agar dilution and broth microdilution lead to inconsistent minimal inhibitory concentrations and may be cause for reevaluating testing methods for
    Bixby ML; Daley EC; Collins LB; Salay JM; Bryson AL; Hirsch EB
    Microbiol Spectr; 2024 Aug; 12(8):e0420523. PubMed ID: 38940588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Assessment of 2 automated microdilution techniques compared to an agar dilution method in determining sensitivity to fosfomycin in strains of carbapenem-resistant Pseudomonas aeruginosa].
    Gil-Romero Y; Regodón-Domínguez M; Wilhelmi de Cal I; López-Fabal F; Gómez-Garcés JL
    Enferm Infecc Microbiol Clin; 2016; 34(7):406-8. PubMed ID: 26620604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter Evaluation of the New Etest Gradient Diffusion Method for Piperacillin-Tazobactam Susceptibility Testing of
    García-Fernández S; Bala Y; Armstrong T; García-Castillo M; Burnham CA; Wallace MA; Hardy D; Zambardi G; Cantón R
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31597745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wide variability in Pseudomonas aeruginosa aminoglycoside results among seven susceptibility testing procedures.
    Staneck JL; Glenn S; DiPersio JR; Leist PA
    J Clin Microbiol; 1989 Oct; 27(10):2277-85. PubMed ID: 2511223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fosfomycin susceptibility of urinary Escherichia coli isolates producing extended-spectrum beta-lactamase according to CLSI and EUCAST recommendations].
    Cağan Aktaş S; Gençer S; Batırel A; Hacıseyitoğlu D; Ozer S
    Mikrobiyol Bul; 2014 Oct; 48(4):545-55. PubMed ID: 25492650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fosfomycin Disk Diffusion Testing among Klebsiella pneumoniae Results in Frequent Inner Colonies and Categorical Disagreement Based on Conflicting Breakpoint Organization Recommendations.
    Bixby ML; Salay JM; Krueger AR; Mathers AJ; Hirsch EB
    Microbiol Spectr; 2023 Mar; 11(2):e0336322. PubMed ID: 36877020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of inoculum and mutant frequency on fosfomycin MIC discrepancies by agar dilution and broth microdilution methods in Enterobacteriaceae.
    Ballestero-Téllez M; Docobo-Pérez F; Rodríguez-Martínez JM; Conejo MC; Ramos-Guelfo MS; Blázquez J; Rodríguez-Baño J; Pascual A
    Clin Microbiol Infect; 2017 May; 23(5):325-331. PubMed ID: 28062317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of fosfomycin and comparison of several susceptibility testing methods against contemporary urine isolates.
    Hirsch EB; Raux BR; Zucchi PC; Kim Y; McCoy C; Kirby JE; Wright SB; Eliopoulos GM
    Int J Antimicrob Agents; 2015 Dec; 46(6):642-7. PubMed ID: 26498988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Three Different Commercial Methods for Fosfomycin Susceptibility Testing in
    Peradotto M; Bondi A; Bianco G; Iannaccone M; Barbui AM; Costa C; Cavallo R
    Microb Drug Resist; 2022 Sep; 28(9):911-915. PubMed ID: 35951075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation of Fosfomycin Susceptibility in Extended Spectrum Beta-Lactamase Producing Enteric Bacteria by Disk Diffusion, Automated System and Agar Dilütion Kit].
    Soydan G; Görgülü Y; Öztürk C
    Mikrobiyol Bul; 2021 Oct; 55(4):617-625. PubMed ID: 34666660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic analysis of Fosfomycin resistance in multi-drug resistant uropathogens and comparison of
    Bir R; Mohapatra S; Kumar A; Arif N; Tyagi S; Ak AP; Gautam H; Sood S; Das BK; Kapil A
    Iran J Microbiol; 2022 Oct; 14(5):636-644. PubMed ID: 36531821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibilities of commonly encountered bacterial isolates to fosfomycin determined by agar dilution and disk diffusion methods.
    Lu CL; Liu CY; Huang YT; Liao CH; Teng LJ; Turnidge JD; Hsueh PR
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4295-301. PubMed ID: 21670185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.